Acumen Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating | 42 | 0 (0.0%) | 1 (2.4%) | 26 (61.9%) | 0 (0.0%) |
Aegis Subscribe to MarketBeat All Access for the recommendation accuracy rating | 14 | 0 (0.0%) | 1 (7.1%) | 13 (92.9%) | 0 (0.0%) |
Alembic Global Advisors Subscribe to MarketBeat All Access for the recommendation accuracy rating | 11 | 0 (0.0%) | 8 (72.7%) | 3 (27.3%) | 0 (0.0%) |
Alliance Global Partners Subscribe to MarketBeat All Access for the recommendation accuracy rating | 117 | 2 (1.7%) | 13 (11.1%) | 59 (50.4%) | 0 (0.0%) |
Argus Subscribe to MarketBeat All Access for the recommendation accuracy rating | 244 | 2 (0.8%) | 49 (20.1%) | 144 (59.0%) | 0 (0.0%) |
Ascendiant Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating | 18 | 0 (0.0%) | 0 (0.0%) | 18 (100.0%) | 0 (0.0%) |
|
Atb Cap Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating | 47 | 1 (2.1%) | 19 (40.4%) | 25 (53.2%) | 0 (0.0%) |
ATB Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating | 259 | 0 (0.0%) | 29 (11.2%) | 134 (51.7%) | 1 (0.4%) |
Atlantic Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating | 27 | 2 (7.4%) | 15 (55.6%) | 7 (25.9%) | 0 (0.0%) |
B. Riley Subscribe to MarketBeat All Access for the recommendation accuracy rating | 731 | 5 (0.7%) | 175 (23.9%) | 440 (60.2%) | 0 (0.0%) |
Bank Of America (Bofa) Subscribe to MarketBeat All Access for the recommendation accuracy rating | 12 | 2 (16.7%) | 4 (33.3%) | 2 (16.7%) | 0 (0.0%) |
Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating | 1961 | 249 (12.7%) | 438 (22.3%) | 635 (32.4%) | 0 (0.0%) |
Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating | 3736 | 359 (9.6%) | 1068 (28.6%) | 1355 (36.3%) | 0 (0.0%) |
Barrington Research Subscribe to MarketBeat All Access for the recommendation accuracy rating | 287 | 0 (0.0%) | 18 (6.3%) | 236 (82.2%) | 0 (0.0%) |
Benchmark Subscribe to MarketBeat All Access for the recommendation accuracy rating | 767 | 9 (1.2%) | 59 (7.7%) | 640 (83.4%) | 1 (0.1%) |
Berenberg Bank Subscribe to MarketBeat All Access for the recommendation accuracy rating | 911 | 4 (0.4%) | 174 (19.1%) | 607 (66.6%) | 0 (0.0%) |
Bloom Burton Subscribe to MarketBeat All Access for the recommendation accuracy rating | 13 | 0 (0.0%) | 5 (38.5%) | 8 (61.5%) | 0 (0.0%) |
BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating | 1993 | 17 (0.9%) | 585 (29.4%) | 708 (35.5%) | 0 (0.0%) |
BNP Paribas Subscribe to MarketBeat All Access for the recommendation accuracy rating | 260 | 61 (23.5%) | 109 (41.9%) | 90 (34.6%) | 0 (0.0%) |
Brookline Capital Management Subscribe to MarketBeat All Access for the recommendation accuracy rating | 24 | 0 (0.0%) | 15 (62.5%) | 9 (37.5%) | 0 (0.0%) |
BTIG Research Subscribe to MarketBeat All Access for the recommendation accuracy rating | 403 | 5 (1.2%) | 79 (19.6%) | 225 (55.8%) | 0 (0.0%) |
BWS Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating | 32 | 1 (3.1%) | 3 (9.4%) | 26 (81.3%) | 0 (0.0%) |
Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | 563 | 3 (0.5%) | 97 (17.2%) | 425 (75.5%) | 0 (0.0%) |
Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating | 1055 | 8 (0.8%) | 159 (15.1%) | 815 (77.3%) | 0 (0.0%) |
Capital One Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating | 67 | 0 (0.0%) | 21 (31.3%) | 45 (67.2%) | 0 (0.0%) |
Chardan Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating | 142 | 2 (1.4%) | 15 (10.6%) | 110 (77.5%) | 0 (0.0%) |
CIBC Subscribe to MarketBeat All Access for the recommendation accuracy rating | 1092 | 12 (1.1%) | 345 (31.6%) | 370 (33.9%) | 0 (0.0%) |
Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating | 2742 | 108 (3.9%) | 1000 (36.5%) | 1176 (42.9%) | 1 (0.0%) |
CJS Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating | 14 | 0 (0.0%) | 5 (35.7%) | 9 (64.3%) | 0 (0.0%) |
CL King Subscribe to MarketBeat All Access for the recommendation accuracy rating | 40 | 0 (0.0%) | 8 (20.0%) | 24 (60.0%) | 1 (2.5%) |
CLSA Subscribe to MarketBeat All Access for the recommendation accuracy rating | 24 | 6 (25.0%) | 0 (0.0%) | 13 (54.2%) | 0 (0.0%) |
Compass Point Subscribe to MarketBeat All Access for the recommendation accuracy rating | 112 | 8 (7.1%) | 29 (25.9%) | 41 (36.6%) | 0 (0.0%) |
Cormark Subscribe to MarketBeat All Access for the recommendation accuracy rating | 280 | 3 (1.1%) | 23 (8.2%) | 44 (15.7%) | 2 (0.7%) |
Craig Hallum Subscribe to MarketBeat All Access for the recommendation accuracy rating | 312 | 0 (0.0%) | 72 (23.1%) | 177 (56.7%) | 0 (0.0%) |
Credit Suisse Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | 463 | 18 (3.9%) | 98 (21.2%) | 137 (29.6%) | 0 (0.0%) |
CSFB Subscribe to MarketBeat All Access for the recommendation accuracy rating | 70 | 2 (2.9%) | 20 (28.6%) | 24 (34.3%) | 0 (0.0%) |
DA Davidson Subscribe to MarketBeat All Access for the recommendation accuracy rating | 681 | 3 (0.4%) | 205 (30.1%) | 323 (47.4%) | 0 (0.0%) |
Daiwa Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating | 51 | 3 (5.9%) | 25 (49.0%) | 23 (45.1%) | 0 (0.0%) |
Danske Subscribe to MarketBeat All Access for the recommendation accuracy rating | 29 | 4 (13.8%) | 14 (48.3%) | 11 (37.9%) | 0 (0.0%) |
Dawson James Subscribe to MarketBeat All Access for the recommendation accuracy rating | 11 | 0 (0.0%) | 4 (36.4%) | 2 (18.2%) | 0 (0.0%) |
Better than Bitcoin? The Biotech Stock with 46,751% Potential (Ad) 4x Better than Bitcoin
Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December. Get the name of the stock here >>> |
Desjardins Subscribe to MarketBeat All Access for the recommendation accuracy rating | 516 | 2 (0.4%) | 119 (23.1%) | 311 (60.3%) | 2 (0.4%) |
Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating | 1177 | 26 (2.2%) | 348 (29.6%) | 389 (33.1%) | 1 (0.1%) |
DNB Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating | 55 | 7 (12.7%) | 27 (49.1%) | 21 (38.2%) | 0 (0.0%) |
DZ Bank Subscribe to MarketBeat All Access for the recommendation accuracy rating | 37 | 6 (16.2%) | 17 (45.9%) | 14 (37.8%) | 0 (0.0%) |
Echelon Wealth Partners Subscribe to MarketBeat All Access for the recommendation accuracy rating | 39 | 0 (0.0%) | 3 (7.7%) | 35 (89.7%) | 1 (2.6%) |
Edward Jones Subscribe to MarketBeat All Access for the recommendation accuracy rating | 25 | 0 (0.0%) | 16 (64.0%) | 9 (36.0%) | 0 (0.0%) |
Eight Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating | 76 | 0 (0.0%) | 10 (13.2%) | 54 (71.1%) | 0 (0.0%) |
Erste Group Bank Subscribe to MarketBeat All Access for the recommendation accuracy rating | 14 | 0 (0.0%) | 9 (64.3%) | 5 (35.7%) | 0 (0.0%) |
Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating | 913 | 24 (2.6%) | 269 (29.5%) | 420 (46.0%) | 0 (0.0%) |
Fundamental Research Subscribe to MarketBeat All Access for the recommendation accuracy rating | 50 | 0 (0.0%) | 2 (4.0%) | 48 (96.0%) | 0 (0.0%) |
Gordon Haskett Subscribe to MarketBeat All Access for the recommendation accuracy rating | 38 | 4 (10.5%) | 15 (39.5%) | 19 (50.0%) | 0 (0.0%) |
Guggenheim Subscribe to MarketBeat All Access for the recommendation accuracy rating | 487 | 17 (3.5%) | 76 (15.6%) | 251 (51.5%) | 0 (0.0%) |
Handelsbanken Subscribe to MarketBeat All Access for the recommendation accuracy rating | 29 | 1 (3.4%) | 13 (44.8%) | 15 (51.7%) | 0 (0.0%) |
Haywood Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating | 27 | 0 (0.0%) | 1 (3.7%) | 5 (18.5%) | 0 (0.0%) |
HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | 2017 | 6 (0.3%) | 107 (5.3%) | 1730 (85.8%) | 0 (0.0%) |
Hovde Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | 66 | 0 (0.0%) | 31 (47.0%) | 35 (53.0%) | 0 (0.0%) |
HSBC Subscribe to MarketBeat All Access for the recommendation accuracy rating | 599 | 56 (9.3%) | 260 (43.4%) | 228 (38.1%) | 0 (0.0%) |
Imperial Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating | 11 | 0 (0.0%) | 4 (36.4%) | 6 (54.5%) | 0 (0.0%) |
Industrial Alliance Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating | 11 | 0 (0.0%) | 0 (0.0%) | 10 (90.9%) | 1 (9.1%) |
Investec Subscribe to MarketBeat All Access for the recommendation accuracy rating | 28 | 5 (17.9%) | 11 (39.3%) | 12 (42.9%) | 0 (0.0%) |
Itau BBA Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating | 10 | 2 (20.0%) | 5 (50.0%) | 3 (30.0%) | 0 (0.0%) |
Janney Montgomery Scott Subscribe to MarketBeat All Access for the recommendation accuracy rating | 66 | 1 (1.5%) | 27 (40.9%) | 38 (57.6%) | 0 (0.0%) |
Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | 1635 | 48 (2.9%) | 544 (33.3%) | 772 (47.2%) | 1 (0.1%) |
JMP Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating | 938 | 0 (0.0%) | 86 (9.2%) | 750 (80.0%) | 0 (0.0%) |
Johnson Rice Subscribe to MarketBeat All Access for the recommendation accuracy rating | 15 | 0 (0.0%) | 7 (46.7%) | 8 (53.3%) | 0 (0.0%) |
Jonestrading Subscribe to MarketBeat All Access for the recommendation accuracy rating | 61 | 0 (0.0%) | 10 (16.4%) | 51 (83.6%) | 0 (0.0%) |
JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating | 3255 | 326 (10.0%) | 1111 (34.1%) | 1330 (40.9%) | 2 (0.1%) |
Keefe, Bruyette & Woods Subscribe to MarketBeat All Access for the recommendation accuracy rating | 531 | 31 (5.8%) | 298 (56.1%) | 185 (34.8%) | 0 (0.0%) |
Kepler Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating | 13 | 1 (7.7%) | 6 (46.2%) | 6 (46.2%) | 0 (0.0%) |
KeyCorp Subscribe to MarketBeat All Access for the recommendation accuracy rating | 851 | 14 (1.6%) | 77 (9.0%) | 661 (77.7%) | 0 (0.0%) |
LADENBURG THALM/SH SH Subscribe to MarketBeat All Access for the recommendation accuracy rating | 99 | 1 (1.0%) | 29 (29.3%) | 36 (36.4%) | 0 (0.0%) |
Lake Street Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating | 163 | 0 (0.0%) | 20 (12.3%) | 85 (52.1%) | 0 (0.0%) |
Laurentian Subscribe to MarketBeat All Access for the recommendation accuracy rating | 31 | 0 (0.0%) | 6 (19.4%) | 14 (45.2%) | 0 (0.0%) |
Leerink Partnrs Subscribe to MarketBeat All Access for the recommendation accuracy rating | 107 | 1 (0.9%) | 46 (43.0%) | 60 (56.1%) | 0 (0.0%) |
Liberum Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating | 41 | 5 (12.2%) | 19 (46.3%) | 17 (41.5%) | 0 (0.0%) |
Lifesci Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating | 17 | 0 (0.0%) | 4 (23.5%) | 13 (76.5%) | 0 (0.0%) |
Loop Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating | 303 | 7 (2.3%) | 92 (30.4%) | 87 (28.7%) | 0 (0.0%) |
Macquarie Subscribe to MarketBeat All Access for the recommendation accuracy rating | 106 | 3 (2.8%) | 34 (32.1%) | 64 (60.4%) | 0 (0.0%) |
Maxim Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | 139 | 0 (0.0%) | 31 (22.3%) | 91 (65.5%) | 0 (0.0%) |
Melius Subscribe to MarketBeat All Access for the recommendation accuracy rating | 17 | 1 (5.9%) | 10 (58.8%) | 6 (35.3%) | 0 (0.0%) |
Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating | 1466 | 40 (2.7%) | 429 (29.3%) | 643 (43.9%) | 0 (0.0%) |
Moffett Nathanson Subscribe to MarketBeat All Access for the recommendation accuracy rating | 28 | 2 (7.1%) | 16 (57.1%) | 10 (35.7%) | 0 (0.0%) |
Monness Crespi & Hardt Subscribe to MarketBeat All Access for the recommendation accuracy rating | 46 | 2 (4.3%) | 17 (37.0%) | 27 (58.7%) | 0 (0.0%) |
Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating | 3244 | 339 (10.5%) | 1621 (50.0%) | 1028 (31.7%) | 4 (0.1%) |
National Bank Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating | 470 | 3 (0.6%) | 27 (5.7%) | 30 (6.4%) | 0 (0.0%) |
National Bankshares Subscribe to MarketBeat All Access for the recommendation accuracy rating | 926 | 18 (1.9%) | 274 (29.6%) | 449 (48.5%) | 0 (0.0%) |
Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | 1715 | 3 (0.2%) | 99 (5.8%) | 1518 (88.5%) | 6 (0.3%) |
New Street Research Subscribe to MarketBeat All Access for the recommendation accuracy rating | 28 | 1 (3.6%) | 14 (50.0%) | 13 (46.4%) | 0 (0.0%) |
Noble Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating | 31 | 0 (0.0%) | 11 (35.5%) | 20 (64.5%) | 0 (0.0%) |
Nomura Subscribe to MarketBeat All Access for the recommendation accuracy rating | 30 | 2 (6.7%) | 15 (50.0%) | 11 (36.7%) | 0 (0.0%) |
Better than Bitcoin? The Biotech Stock with 46,751% Potential (Ad) 4x Better than Bitcoin
Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December. Get the name of the stock here >>> |
Nordea Equity Research Subscribe to MarketBeat All Access for the recommendation accuracy rating | 24 | 1 (4.2%) | 12 (50.0%) | 11 (45.8%) | 0 (0.0%) |
Northcoast Research Subscribe to MarketBeat All Access for the recommendation accuracy rating | 59 | 2 (3.4%) | 26 (44.1%) | 31 (52.5%) | 0 (0.0%) |
Northland Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating | 218 | 1 (0.5%) | 51 (23.4%) | 105 (48.2%) | 0 (0.0%) |
Numis Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating | 83 | 4 (4.8%) | 11 (13.3%) | 68 (81.9%) | 0 (0.0%) |
Odeon Capital Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | 28 | 2 (7.1%) | 13 (46.4%) | 13 (46.4%) | 0 (0.0%) |
Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating | 1077 | 0 (0.0%) | 160 (14.9%) | 810 (75.2%) | 1 (0.1%) |
OTR Global Subscribe to MarketBeat All Access for the recommendation accuracy rating | 25 | 0 (0.0%) | 0 (0.0%) | 20 (80.0%) | 0 (0.0%) |
Panmure Gordon Subscribe to MarketBeat All Access for the recommendation accuracy rating | 11 | 1 (9.1%) | 5 (45.5%) | 5 (45.5%) | 0 (0.0%) |
Pareto Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating | 28 | 0 (0.0%) | 10 (35.7%) | 18 (64.3%) | 0 (0.0%) |
Peel Hunt Subscribe to MarketBeat All Access for the recommendation accuracy rating | 102 | 1 (1.0%) | 31 (30.4%) | 69 (67.6%) | 0 (0.0%) |
Pi Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating | 75 | 1 (1.3%) | 9 (12.0%) | 44 (58.7%) | 0 (0.0%) |
Pickering Energy Partners Subscribe to MarketBeat All Access for the recommendation accuracy rating | 13 | 2 (15.4%) | 4 (30.8%) | 7 (53.8%) | 0 (0.0%) |
Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating | 2331 | 79 (3.4%) | 735 (31.5%) | 1008 (43.2%) | 0 (0.0%) |
Piper Sandler Companies Subscribe to MarketBeat All Access for the recommendation accuracy rating | 22 | 2 (9.1%) | 10 (45.5%) | 9 (40.9%) | 0 (0.0%) |
Pivotal Research Subscribe to MarketBeat All Access for the recommendation accuracy rating | 35 | 3 (8.6%) | 4 (11.4%) | 11 (31.4%) | 0 (0.0%) |
R. F. Lafferty Subscribe to MarketBeat All Access for the recommendation accuracy rating | 10 | 1 (10.0%) | 5 (50.0%) | 4 (40.0%) | 0 (0.0%) |
Raymond James Subscribe to MarketBeat All Access for the recommendation accuracy rating | 2263 | 13 (0.6%) | 272 (12.0%) | 1130 (49.9%) | 428 (18.9%) |
Redburn Atlantic Subscribe to MarketBeat All Access for the recommendation accuracy rating | 86 | 12 (14.0%) | 46 (53.5%) | 27 (31.4%) | 0 (0.0%) |
Redburn Partners Subscribe to MarketBeat All Access for the recommendation accuracy rating | 29 | 3 (10.3%) | 9 (31.0%) | 17 (58.6%) | 0 (0.0%) |
Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating | 1056 | 7 (0.7%) | 228 (21.6%) | 450 (42.6%) | 0 (0.0%) |
Rosenblatt Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating | 460 | 23 (5.0%) | 90 (19.6%) | 324 (70.4%) | 0 (0.0%) |
Roth Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating | 112 | 2 (1.8%) | 29 (25.9%) | 81 (72.3%) | 0 (0.0%) |
Roth Mkm Subscribe to MarketBeat All Access for the recommendation accuracy rating | 533 | 7 (1.3%) | 118 (22.1%) | 408 (76.5%) | 0 (0.0%) |
Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating | 3642 | 63 (1.7%) | 1110 (30.5%) | 1895 (52.0%) | 0 (0.0%) |
Sanford C. Bernstein Subscribe to MarketBeat All Access for the recommendation accuracy rating | 332 | 21 (6.3%) | 124 (37.3%) | 131 (39.5%) | 0 (0.0%) |
Scotiabank Subscribe to MarketBeat All Access for the recommendation accuracy rating | 1146 | 17 (1.5%) | 393 (34.3%) | 426 (37.2%) | 0 (0.0%) |
Seaport Res Ptn Subscribe to MarketBeat All Access for the recommendation accuracy rating | 130 | 7 (5.4%) | 52 (40.0%) | 71 (54.6%) | 0 (0.0%) |
Shore Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating | 900 | 26 (2.9%) | 119 (13.2%) | 401 (44.6%) | 0 (0.0%) |
Sidoti Subscribe to MarketBeat All Access for the recommendation accuracy rating | 26 | 0 (0.0%) | 18 (69.2%) | 7 (26.9%) | 0 (0.0%) |
Societe Generale Subscribe to MarketBeat All Access for the recommendation accuracy rating | 71 | 10 (14.1%) | 32 (45.1%) | 29 (40.8%) | 0 (0.0%) |
Stephens Subscribe to MarketBeat All Access for the recommendation accuracy rating | 767 | 5 (0.7%) | 290 (37.8%) | 395 (51.5%) | 0 (0.0%) |
Stifel Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating | 37 | 2 (5.4%) | 11 (29.7%) | 24 (64.9%) | 0 (0.0%) |
Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating | 2549 | 11 (0.4%) | 509 (20.0%) | 1293 (50.7%) | 2 (0.1%) |
StockNews.com Subscribe to MarketBeat All Access for the recommendation accuracy rating | 56584 | 14105 (24.9%) | 29109 (51.4%) | 10682 (18.9%) | 2688 (4.8%) |
Summit Insights Subscribe to MarketBeat All Access for the recommendation accuracy rating | 11 | 1 (9.1%) | 5 (45.5%) | 5 (45.5%) | 0 (0.0%) |
Susquehanna Subscribe to MarketBeat All Access for the recommendation accuracy rating | 698 | 11 (1.6%) | 223 (31.9%) | 361 (51.7%) | 0 (0.0%) |
SVB Leerink Subscribe to MarketBeat All Access for the recommendation accuracy rating | 116 | 3 (2.6%) | 47 (40.5%) | 63 (54.3%) | 0 (0.0%) |
SVB Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating | 48 | 2 (4.2%) | 15 (31.3%) | 17 (35.4%) | 0 (0.0%) |
TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating | 811 | 9 (1.1%) | 285 (35.1%) | 516 (63.6%) | 0 (0.0%) |
TD Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating | 1078 | 2 (0.2%) | 287 (26.6%) | 515 (47.8%) | 33 (3.1%) |
Telsey Advisory Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | 498 | 0 (0.0%) | 234 (47.0%) | 256 (51.4%) | 0 (0.0%) |
The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | 1807 | 249 (13.8%) | 670 (37.1%) | 803 (44.4%) | 18 (1.0%) |
TheStreet Subscribe to MarketBeat All Access for the recommendation accuracy rating | 2437 | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) |
Tigress Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating | 75 | 0 (0.0%) | 0 (0.0%) | 46 (61.3%) | 14 (18.7%) |
Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating | 2326 | 10 (0.4%) | 654 (28.1%) | 1283 (55.2%) | 0 (0.0%) |
Tudor, Pickering, Holt & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating | 14 | 2 (14.3%) | 6 (42.9%) | 6 (42.9%) | 0 (0.0%) |
UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | 1845 | 105 (5.7%) | 807 (43.7%) | 706 (38.3%) | 0 (0.0%) |
Veritas Investment Research Subscribe to MarketBeat All Access for the recommendation accuracy rating | 33 | 15 (45.5%) | 0 (0.0%) | 12 (36.4%) | 0 (0.0%) |
Vertical Research Subscribe to MarketBeat All Access for the recommendation accuracy rating | 31 | 0 (0.0%) | 14 (45.2%) | 17 (54.8%) | 0 (0.0%) |
Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating | 1473 | 37 (2.5%) | 466 (31.6%) | 870 (59.1%) | 0 (0.0%) |
Better than Bitcoin? The Biotech Stock with 46,751% Potential (Ad) 4x Better than Bitcoin
Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December. Get the name of the stock here >>> |
Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating | 2121 | 146 (6.9%) | 773 (36.4%) | 869 (41.0%) | 0 (0.0%) |
Westpark Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating | 23 | 0 (0.0%) | 9 (39.1%) | 13 (56.5%) | 0 (0.0%) |
William Blair Subscribe to MarketBeat All Access for the recommendation accuracy rating | 382 | 0 (0.0%) | 116 (30.4%) | 266 (69.6%) | 0 (0.0%) |
Williams Trading Subscribe to MarketBeat All Access for the recommendation accuracy rating | 23 | 8 (34.8%) | 11 (47.8%) | 4 (17.4%) | 0 (0.0%) |
Wolfe Research Subscribe to MarketBeat All Access for the recommendation accuracy rating | 389 | 38 (9.8%) | 162 (41.6%) | 172 (44.2%) | 0 (0.0%) |
Zelman & Associates Subscribe to MarketBeat All Access for the recommendation accuracy rating | 13 | 2 (15.4%) | 2 (15.4%) | 9 (69.2%) | 0 (0.0%) |